Montelukast + Placebo
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Acute Otitis Media
Conditions
Acute Otitis Media, Otitis Media, Ear Infection
Trial Timeline
Mar 1, 2004 → Dec 1, 2005
NCT ID
NCT00189462About Montelukast + Placebo
Montelukast + Placebo is a approved stage product being developed by Merck for Acute Otitis Media. The current trial status is completed. This product is registered under clinical trial identifier NCT00189462. Target conditions include Acute Otitis Media, Otitis Media, Ear Infection.
What happened to similar drugs?
20 of 20 similar drugs in Acute Otitis Media were approved
Approved (20) Terminated (4) Active (0)
✅Modification of Prasugrel based on a biological assay + prasugrel / clopidogrelDaiichi SankyoApproved
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (6)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00599534 | Phase 2 | Withdrawn |
| NCT00406094 | Approved | UNKNOWN |
| NCT00189462 | Approved | Completed |
| NCT00189475 | Approved | Completed |
| NCT00590772 | Approved | Completed |
| NCT01011452 | Approved | Completed |
Competing Products
20 competing products in Acute Otitis Media